GlassScriptPhysician profile
Seena Safavy
NPI 1437418332
$2,611.33
in general payments reported to CMS, 2019-2025
12 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.97 · 2024: $1,912 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,753 · Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,752.94 |
| Food and Beverage | $802.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,825.90 | 2019-2024 | |
| Boston Scientific Corporation | $330.89 | 2025 | Lithoclast, Spaceoar System, Ams 700 |
| Smith+Nephew, INC. | $108.68 | 2024 | Stravix |
| Calyxo, INC. | $70.15 | 2025 | Cvac Aspiration System |
| Procept Biorobotics Corporation | $49.61 | 2025 | |
| Innovation Technologies INC | $46.53 | 2025 | Irrisept |
| Ferring Pharmaceuticals INC. | $39.65 | 2025 | Adstiladrin |
| Janssen Biotech, INC. | $34.00 | 2025 | Erleada |
| Lilly USA, LLC | $33.37 | 2024 | Verzenio, Retevmo, Jaypirca |
| Urogen Pharma, INC. | $31.37 | 2025 | |
| Angiodynamics, INC. | $20.64 | 2025 | Nanoknife |
| Coloplast Corp | $20.54 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seena Safavy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.